IPO - iBio, Inc.

Form Type: 424B5

Filing Date: 2025-04-30

Corporate Action: Ipo

Type: Update

Accession Number: 000110465925041850

Filing Summary: On April 30, 2025, iBio, Inc. filed a prospectus supplement updating details regarding their offering of 1,530,769 shares of common stock and associated warrants. The Series A Warrants allow the purchase of up to 3,365,385 shares and have been amended to lower the exercise price to $0.86 per share. The company's common stock became listed on The Nasdaq Capital Market under the symbol 'IBIO' on March 4, 2025, transitioning from the NYSE American. The closing price of the common stock on April 28, 2025, was $1.05 per share. Investors are cautioned about the high degree of risk involved in investing in the securities, which should be reviewed in the 'Risk Factors' section of the filings. The prospectus supplement is intended to be read in conjunction with the original prospectus from December 7, 2020, and any prior amendments or supplements.